Clinical studies show that serra-peptase induces fibrinolytic, anti-inflammatory and anti-edemic (prevents swelling and fluid retention) activity in a number of tissues, and that its anti-inflammatory effects are superior to other proteolytic enzymes.
Besides reducing inflammation, one of serrapeptase’s most profound benefits is reduction of pain, due to its ability to block the release of pain-inducing amines from inflamed tissues.
Physicians throughout Europe and Asia have recognized the anti-inflammatory and
pain-blocking benefits of this naturally occurring substance and are using it in treatment as an
alternative to salicylates, ibuprofen, and other NSAIDs.
In Germany and other European countries, serrapeptase is a common treatment for inflammatory and traumatic swellings.